Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Sep;69(9):1354-63.
doi: 10.4088/jcp.v69n0902. Epub 2008 Sep 9.

Cannabis withdrawal in the United States: results from NESARC

Deborah S Hasin  1 , Katherine M Keyes, Donald Alderson, Shuang Wang, Efrat Aharonovich, Bridget F Grant
Affiliations

Cannabis withdrawal in the United States: results from NESARC

Deborah S Hasin et al. J Clin Psychiatry. 2008 Sep.

Abstract

Objective: Although cannabis is the most widely abused illicit drug, little is known about the prevalence of cannabis withdrawal and its factor structure, clinical validity, and psychiatric correlates in the general population.

Method: National Epidemiologic Survey on Alcohol and Related Conditions participants were assessed, in 2001-2002, with structured in-person interviews covering substance history, DSM-IV Axis I and II disorders, and withdrawal symptoms after cessation of use. Of these, 2613 had been frequent cannabis users (> or = 3 times/week), and a "cannabis-only" subset (N = 1119) never binge-drank or used other drugs > or = 3 times/week.

Results: In the full sample and subset, 44.3% (SE = 1.19) and 44.2% (SE = 1.75), respectively, experienced > or = 2 cannabis withdrawal symptoms, while 34.4% (SE = 1.21) and 34.1% (SE = 1.76), respectively, experienced > or = 3 symptoms. The symptoms formed 2 factors, one characterized by weakness, hypersomnia, and psychomotor retardation and the second by anxiety, restlessness, depression, and insomnia. Both symptom types were associated with significant distress/impairment (p < .01), substance use to relieve/avoid cannabis withdrawal symptoms (p <.01), and quantity of cannabis use (among the cannabis-only users p < .05). Panic (p < .01) and personality (p > .01) disorders were associated with anxiety symptoms in both samples, family history of drug problems was associated with weakness symptoms in the subset (p = .01), and depression was associated with both sets of symptoms in the subset (p < or = .05).

Conclusion: Cannabis withdrawal was prevalent and clinically significant among a representative sample of frequent cannabis users. Similar results in the subset without polysubstance abuse confirmed the specificity of symptoms to cannabis. Cannabis withdrawal should be added to DSM-V, and the etiology and treatment implications of cannabis withdrawal symptoms should be investigated.

PubMed Disclaimer

References

    1. Compton WM, Grant BF, Colliver JD, et al. Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. JAMA. 2004;291:2114–2121. - PubMed
    1. ElSohly MA, Ross SA, Mehmedic Z, et al. Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980–1997. J Forensic Sci. 2000;45:24–30. - PubMed
    1. Substance Abuse and Mental Health Services Administration (SAMHSA) Office of Applied Statistics, Treatment Episode Data Set (TEDS), Highlights 2002, National Admissions to Substance Abuse Treatment Services DASIS Series S-22, DHHS Publication number (SMA) 04-3946. Rockville MD: 2004.
    1. Colliver JD, Compton WM, Gfroerer JC, et al. Projecting drug use among aging baby boomers in 2020. Ann Epidemiol. 2006;16:257–265. - PubMed
    1. Hasin D, Hatzenbuehler ML, Keyes K, et al. Substance use disorders: diagnostic and statistical manual of mental disorders, fourth edition (DSM-IV) and international classification of diseases, tenth edition (ICD-10) Addiction. 2006;101(Suppl 1):59–75. - PubMed

Publication types

MeSH terms

LinkOut - more resources